Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
RevMab
anti-CD79a (C-term) (human), Rabbit Monoclonal (RM297)
Product Details | |
---|---|
Synonyms | B-cell Antigen Receptor Complex-associated Protein alpha Chain; Membrane-bound Immunoglobulin-associated Protein |
Product Type | Recombinant Antibody |
Properties | |
Clone | RM297 |
Isotype | Rabbit IgG |
Source/Host | Rabbit |
Immunogen/Antigen | A peptide corresponding to the C-terminus of human CD79a. |
Application |
Immunohistochemistry (IHC): 1:100-1:200 dilution |
Crossreactivity | Human |
Specificity |
This antibody reacts to human CD79a. |
Purity | Protein A purified. |
Purity Detail | Protein A affinity purified from an animal origin-free culture supernatant. |
Concentration | N/A |
Formulation | Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide. |
Isotype Negative Control | |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Accession Number | P11912 |
Declaration | Manufactured by RevMab Biosciences. |
Shipping and Handling | |
Shipping | BLUE ICE |
Long Term Storage | -20°C |
Handling Advice | Avoid freeze/thaw cycles. |
Use/Stability | Stable for at least 1 year after receipt when stored at -20°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
CD79a is a disulphide-linked heterodimer together with CD79b. CD79a plays multiple and diverse roles in B cell development and function. The CD79a/b heterodimer associates non-covalently with the immunoglobulin heavy chain through its transmembrane region, thus forming the BCR along with the immunoglobulin light chain and the pre-BCR when associated with the surrogate light chain in developing B cells. Association of the CD79a/b heterodimer with the immunoglobulin heavy chain is required for surface expression of the BCR and BCR induced calcium flux and protein tyrosine phosphorylation. The CD79a protein is present on the surface of B-cells throughout their life cycle, and is absent on all other healthy cells, making it a highly reliable marker for B-cells in immunohistochemistry. The protein remains present when B cells transform into active plasma cells, and is also present in virtually all B-cell neoplasms, including B-cell lymphomas, plasmacytomas and myelomas. It is also present in abnormal lymphocytes associated with some cases of Hodgkins disease. Because even on B cell precursors, it can be used to stain a wider range of cells compared to the alternative B cell marker CD20 and is often used together in immunohistochemistry panels.